We provide an up-to-date review of the pharmacological treatment of neuropathic pain with
emphasis on the latest evidence-based recommendations for its pharmacological treatment …

Neuropathic pain, comprising a range of heterogeneous conditions, is often severe and
difficult to manage, and this may result in a chronic condition that negatively affects the …

Background New drug treatments, clinical trials, and standards of quality for assessment of
evidence justify an update of evidence-based recommendations for the pharmacological …

The Neuropathic Pain Special Interest Group of the International Association for the Study of
Pain recently sponsored the development of evidence-based guidelines for the …

Neuropathic pain (NP) is a significant medical and socioeconomic burden. Epidemiological
surveys have indicated that many patients with NP do not receive appropriate treatment for …

Pharmacology and treatment of neuropathic pains : Current Opinion in Neurology
Pharmacology and treatment of neuropathic pains : Current Opinion in Neurology Log in or …

A number of different treatments for neuropathic pain have been studied, but the literature is
sizable, rapidly evolving, and lacks important information about practical aspects of patient …

Patients with neuropathic pain (NP) are challenging to manage and evidence-based clinical
recommendations for pharmacologic management are needed. Systematic literature …

Neuropathic pain, caused by a lesion or disease affecting the somatosensory system, affects
between 3 and 17% of the general population. The treatment of neuropathic pain is …

Neuropathic pain remains a significant unmet need. French recommendations were updated
in 2020. The goal of this minireview is to provide an update on these published guidelines …